Sino Biopharmaceutical Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'21 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2021 is 21.64% vs -3.26% in Jun 2020",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2021 is 706.65% vs -18.76% in Jun 2020",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'21",
        "Jun'20",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,547.10",
          "val2": "7,026.70",
          "chgp": "21.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,440.90",
          "val2": "2,098.90",
          "chgp": "16.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "90.80",
          "val2": "91.70",
          "chgp": "-0.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "64.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,711.00",
          "val2": "1,079.90",
          "chgp": "706.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "255.90%",
          "val2": "250.40%",
          "chgp": "0.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 10.31% vs 8.11% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 11.11% vs 1.78% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "34,525.20",
          "val2": "31,297.40",
          "chgp": "10.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8,655.50",
          "val2": "8,135.00",
          "chgp": "6.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "301.80",
          "val2": "320.00",
          "chgp": "-5.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,734.60",
          "val2": "-1,385.80",
          "chgp": "-25.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,763.70",
          "val2": "5,187.50",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "213.50%",
          "val2": "215.10%",
          "chgp": "-0.16%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'21 - YoY

Jun'21

Jun'20

Change(%)

Net Sales

8,547.10

7,026.70

21.64%

Operating Profit (PBDIT) excl Other Income

2,440.90

2,098.90

16.29%

Interest

90.80

91.70

-0.98%

Exceptional Items

64.10

0.00

Consolidate Net Profit

8,711.00

1,079.90

706.65%

Operating Profit Margin (Excl OI)

255.90%

250.40%

0.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2021 is 21.64% vs -3.26% in Jun 2020

Consolidated Net Profit

YoY Growth in quarter ended Jun 2021 is 706.65% vs -18.76% in Jun 2020

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

34,525.20

31,297.40

10.31%

Operating Profit (PBDIT) excl Other Income

8,655.50

8,135.00

6.40%

Interest

301.80

320.00

-5.69%

Exceptional Items

-1,734.60

-1,385.80

-25.17%

Consolidate Net Profit

5,763.70

5,187.50

11.11%

Operating Profit Margin (Excl OI)

213.50%

215.10%

-0.16%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 10.31% vs 8.11% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 11.11% vs 1.78% in Dec 2024

All Annual Results